AETHLON MEDICAL, INC. Restricted Cash and Cash Equivalents
AETHLON MEDICAL, INC. (AEMD) had Restricted Cash and Cash Equivalents of $9.91 million as of 2021-03-31, per its 10-K filed 2021-06-24.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2021-06-24
- 2021-03-31: Restricted Cash and Cash Equivalents $9.91M.
- 2020-12-31: Restricted Cash and Cash Equivalents $12.18M.
- 2020-03-31: Restricted Cash and Cash Equivalents $9.60M; Restricted Cash and Cash Equivalents as first filed $4.06M.
- 2019-03-31: Restricted Cash and Cash Equivalents $3.83M.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2021-03-31 | $9.91M 10-K · filed 2021-06-24 | |
| 2020-12-31 | $12.18M 10-Q · filed 2021-02-10 | |
| 2020-03-31 | $9.60M 10-K · filed 2021-06-24 | $4.06M 10-Q · filed 2021-02-10 |
| 2019-03-31 | $3.83M 10-K · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |